Cardiovascular Health
Conditions
Keywords
mentoring, children, cardiovascular health
Brief summary
The purpose of this study is to determine whether mentoring is associated with beneficial cardiovascular health effects in both mentors and mentees.
Detailed description
Participants are randomly assigned to either being a mentor or a wait list control. These participants are drawn from a population of undergraduate students. Participants are also randomly assigned to either being a mentee or a wait list control. These participants are drawn from a population of Chicago Public School children. In total, there will be 30 mentors, 30 control mentors, 30 mentees, and 30 control mentees. Participants will come for a laboratory visit in which cardiovascular health measures will be taken (details below). Visits will occur once at baseline (before the intervention starts), and once post-intervention. The protocol will be the same at the two study visits. Participants in the intervention group will engage in one-on-one mentoring sessions (between mentors and mentees) once a week after school for the school year
Interventions
BEHAVIORALMentoring
Youth in the intervention group will participate in one-on-one mentoring sessions (between mentors and mentees) once per week after school. Mentoring sessions will focus on the development of a social bond between mentor and mentee.
Sponsors
Northwestern University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
9 Years to 25 Years
Healthy volunteers
Yes
Inclusion criteria
* Undergraduate student for mentors. * Chicago Public School student for mentees.
Exclusion criteria
* Younger than 9 or older than 14 for mentee conditions.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Obesity [body mass index] | Change in body mass index from baseline to 8 months | BMI in kg/m\^2, weight in kilograms, height in meters |
| Blood Pressure | Change in blood pressure from baseline to 8 months | — |
| Pro-inflammatory cytokines [standardized and averaged value of pro-inflammatory cytokines and CRP] | Change in cytokine composite score from baseline to 8 months | — |
| Cholesterol | Change in cholesterol from baseline to 8 months | — |
| HbA1c | Change in HbA1c from baseline to 8 months | — |
Countries
United States
Outcome results
None listed